Trial Profile
COugh Among Hypertensive Patients Treated With Telmisartan, Who Had to Stop previoUs ACE-I Treatment Due to couGH.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Apr 2014
Price :
$35
*
At a glance
- Drugs Telmisartan (Primary)
- Indications Hypertension
- Focus Adverse reactions
- Acronyms COUGH
- Sponsors Bayer
- 15 Aug 2012 Actual end date changed from Jan 2010 to Dec 2009 as reported by ClinicalTrials.gov.
- 07 Oct 2010 New trial record